NCT03698006View on ClinicalTrials.gov

Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 12, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

June 30, 2022

Conditions
Postoperative PainKnee Osteoarthritis
Interventions
DRUG

Ropivacaine 0.5% Injectable Solution

Tibial nerve block with 10ml of Ropivacaine 0.5%

DRUG

Ropivacaine 0.2% Injectable Solution

Infiltration with 25ml of Ropivacaine 0.2% in the posterior knee capsule

Trial Locations (1)

1004

Eric Albrecht, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT03698006 - Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery | Biotech Hunter | Biotech Hunter